103 related articles for article (PubMed ID: 3429383)
1. Clinical evaluation of roxithromycin in odontogenic orofacial infections.
Sasaki J
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():167-70. PubMed ID: 3429383
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of roxithromycin in odontogenic infection].
Sasaki J; Kaneko A; Takai H; Ikeshima K; Oomura H; Shiiki K; Uematsu M; Morihana T; Tomita F; Hisano Y
Jpn J Antibiot; 1989 May; 42(5):1233-55. PubMed ID: 2664258
[TBL] [Abstract][Full Text] [Related]
3. [A microbiological evaluation of the use of roxithromycin in oral odontogenic infections].
Lo Bue AM; Chisari G; Caruso S; Gismondo MR
Minerva Stomatol; 1993; 42(7-8):355-60. PubMed ID: 8295624
[TBL] [Abstract][Full Text] [Related]
4. In-vitro comparison of roxithromycin and erythromycin against 900 anaerobic bacterial strains.
Dubreuil L
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():13-9. PubMed ID: 3429381
[TBL] [Abstract][Full Text] [Related]
5. [Pathogen spectrum and resistance status of exclusively anaerobic odontogenic infections].
Eckert AW; Höhne C; Schubert J
Mund Kiefer Gesichtschir; 2000 May; 4(3):153-8. PubMed ID: 10900958
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance and prevalence of resistance genes of obligate anaerobes isolated from periodontal abscesses.
Xie Y; Chen J; He J; Miao X; Xu M; Wu X; Xu B; Yu L; Zhang W
J Periodontol; 2014 Feb; 85(2):327-34. PubMed ID: 23659425
[TBL] [Abstract][Full Text] [Related]
7. Clinical and microbiological effects of in vivo miocamycin therapy on oral infections and in surgical prophylaxis.
De Luca M
Drugs Exp Clin Res; 1988; 14(10):659-63. PubMed ID: 3266743
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
Dubreuil L; Devos J; Romond C; Bryskier A
Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
[TBL] [Abstract][Full Text] [Related]
9. Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscesses.
Warnke PH; Becker ST; Springer IN; Haerle F; Ullmann U; Russo PA; Wiltfang J; Fickenscher H; Schubert S
J Craniomaxillofac Surg; 2008 Dec; 36(8):462-7. PubMed ID: 18760616
[TBL] [Abstract][Full Text] [Related]
10. Clindamycin versus ampicillin in the treatment of odontogenic infections.
Mangundjaja S; Hardjawinata K
Clin Ther; 1990; 12(3):242-9. PubMed ID: 2379229
[TBL] [Abstract][Full Text] [Related]
11. [Dentogenic infections-part I: the significance of bacterial isolation of dentogenic infections under routineous conditions].
Eckert AW; Just L; Wilhelms D; Schubert J
Wien Med Wochenschr; 2012 Jul; 162(13-14):316-20. PubMed ID: 22669314
[TBL] [Abstract][Full Text] [Related]
12. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
13. [Bacterial and management of orofacial abscesses--penicillin versus clindamycin].
Mailath G; Lill W; Ertl L; Staus-Rausch E; Porteder H; Matejka M
Z Stomatol; 1988 May; 85(3):179-89. PubMed ID: 3256176
[No Abstract] [Full Text] [Related]
14. [Roxithromycin in dental infections].
Pappalardo G; Rossetti B; Alessandra S; Greco S; Nicoletti G; Gismondo MR; Lo Bue AM
Minerva Stomatol; 1992 Dec; 41(12):577-81. PubMed ID: 1301492
[TBL] [Abstract][Full Text] [Related]
15. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections.
Kuriyama T; Karasawa T; Nakagawa K; Saiki Y; Yamamoto E; Nakamura S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):600-8. PubMed ID: 11077383
[TBL] [Abstract][Full Text] [Related]
16. [Problems of bacteriologic diagnosis and aimed antibiotic therapy in pyogenic maxillofacial infections].
Geiger SA; Gräf W
Dtsch Zahnarztl Z; 1978 Nov; 33(11):771-3. PubMed ID: 367753
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of roxithromycin in treating paediatric patients. A European multicentre study.
Kafetzis DA; Blanc F
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():171-7. PubMed ID: 3429384
[TBL] [Abstract][Full Text] [Related]
18. [The odontogenic abscess. Aetiology, treatment and involvement in the orofacial region].
Spijkervet FK; Vissink A; Raghoebar GM
Ned Tijdschr Tandheelkd; 2004 Apr; 111(4):120-7. PubMed ID: 15129556
[TBL] [Abstract][Full Text] [Related]
19. [Bacteriology of odontogenic abscesses].
Posukidis T; Herholz M
Dtsch Zahnarztl Z; 1978 Nov; 33(11):774-6. PubMed ID: 367754
[TBL] [Abstract][Full Text] [Related]
20. [A trial of the use of rulid, sumamed and makropen in the combined treatment of generalized periodontitis at a stage of exacerbation].
Tsarev VN; Dmitrieva LA; Filatova NA; Romanov AE; Chekhova NO
Stomatologiia (Mosk); 1997; 76(5):4-8. PubMed ID: 9411932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
